https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26036 Wed 11 Apr 2018 10:39:36 AEST ]]> Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:17161 Wed 11 Apr 2018 09:14:19 AEST ]]>